FDA panel nod for Sapien a positive – but Edwards mustn't get ahead of itself, says analyst
This article was originally published in Clinica
Executive Summary
A US FDA advisory panel yesterday voted for the approval of Edwards Lifesciences' Sapien heart valve system for use on inoperable patients with severe aortic stenosis.